Sherri Gordon, CLC is a certified professional life coach, author, and journalist covering health and wellness, social issues, parenting, and mental health. She also has a certificate of ...
In a stock exchange filing, the pharma company said DCGI has approved the manufacturing and marketing of the company’s first ...
The current demography of Western countries shows that the population of older adults will increase steadily in the near future. The budget and human resources devoted to the proper care of this ...
Orchid Pharma has obtained approval from the Drug Controller General of India (DCGI) to manufacture and market an antibiotic ...
Orchid Pharma receives approval from DCGI to manufacture new antibiotic drug for complicated urinary tract infections.
Complicated Urinary Tract Infections Treatment Market is projected to reach USD 16.1 billion by 2033, trailing a CAGR of 5.76 ...
Orchid Pharma on Thursday said it has received approval from regulator DCGI to manufacture and market an antibiotic drug for the treatment of complicated urinary tract infections. The Drug Controller ...
A molecule developed fully in India, enmetazobactam, which has gone on to become the first-ever internationally approved “new ...
DUBLIN and CHICAGO, May 31, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage ...
Orchid Pharma secures approval for new antibiotic drug combination in India to combat serious infections and antimicrobial ...
Orchid Pharma has received DCGI's approval for the manufacturing and marketing its invented, made-in-India Active ...
The company anticipates a successful launch and distribution of Enmetazobactam and its combination with Cefepim to treat ...